Skip to main content

Andrew R. Pearce

Associate

[email protected]

+1.617.348.3069

Share:

Andrew concentrates his practice on corporate transactional matters with an emphasis on securities offerings, corporate governance and ongoing reporting requirements for publicly traded companies. Andrew regularly represents domestic and foreign companies and investment banks in capital markets transactions, including initial public offerings, follow-on equity offerings, ATM offerings and PIPEs. 

Prior to joining Mintz, Andrew served as an associate director of equities, legal & compliance in the New York office of a Canadian-based global investment bank. In that role, he provided regulatory guidance to the company’s capital markets business units, drafted and negotiated agreements and deal documents, and counseled clients on share offerings. He also represented various parties in public and private offerings, including underwriters, purchasers, placement agents, private equity sponsors, and issuers. Earlier, Andrew was an associate and assistant general counsel for a New York-based global financial services company. He was also an analyst in the legal compliance department and a summer associate at another international financial services company.

While in law school, Andrew served as an associate editor of the Syracuse Journal of Science and Technology Law. Before law school, he taught history and coached ice hockey and lacrosse at a boarding school in the Northeast.

Education

  • Syracuse University (JD)
  • University of Virginia (BA)

Viewpoints

Coronavirus Molecule
On May 14, 2020, the Securities and Exchange Commission (“SEC”) approved changes to the NYSE Listed Company Manual to provide a temporary exception to the shareholder approval rules for certain capital raising transactions as a result of the coronavirus (“COVID-19”) pandemic.
Read more
This advisory covers the SEC’s April 21, 2020 approval to allow NYSE-listed companies to regain compliance with stockholders equity/market capitalization and minimum price continued listing standards by tolling applicable compliance periods through June 30, 2020 due to COVID-19.
Read more
This article covers SEC changes, made in response to the COVID-19 pandemic, that give Nasdaq listed companies additional time to regain compliance with certain continued listing requirements regarding the bid price and market value of publicly held shares. Nasdaq Temporarily Extends Compliance Periods for Certain Continued Listing Requirements as a Result of Coronavirus (COVID-19)
Read more
Read about the temporary suspension of NYSE's $15 million minimum market capitalization requirement and shareholder approval rules for certain capital raising transactions.
Read more